Free Trial

Leeward Financial Partners LLC Reduces Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Key Points

  • Leeward Financial Partners LLC has reduced its stake in UnitedHealth Group by 55.9%, trimming its holdings to 946 shares valued at $496,000.
  • Despite the reductions from some investors, UnitedHealth Group's stock remains significantly owned by institutional investors, currently at 87.86%.
  • UnitedHealth recently declared a quarterly dividend increase to $2.21 per share, representing a 3.5% yield, alongside reporting revenue growth of 12.9% year-over-year.
  • Looking to export and analyze UnitedHealth Group data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Leeward Financial Partners LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 55.9% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 946 shares of the healthcare conglomerate's stock after selling 1,198 shares during the quarter. Leeward Financial Partners LLC's holdings in UnitedHealth Group were worth $496,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Financial Management Professionals Inc. lifted its holdings in UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after purchasing an additional 17 shares in the last quarter. Global Wealth Strategies & Associates lifted its holdings in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after purchasing an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 1.0% in the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock worth $1,080,000 after buying an additional 21 shares in the last quarter. Retirement Planning Group LLC lifted its stake in shares of UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after buying an additional 21 shares in the last quarter. Finally, Net Worth Advisory Group lifted its stake in shares of UnitedHealth Group by 0.6% in the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock worth $1,907,000 after buying an additional 21 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Insiders Place Their Bets

In related news, Director Kristen Gil bought 3,700 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO John F. Rex bought 17,175 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the transaction, the chief financial officer directly owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders acquired 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Performance

NYSE:UNH traded up $6.07 during trading hours on Friday, reaching $250.74. 10,146,688 shares of the company's stock were exchanged, compared to its average volume of 18,404,546. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a market capitalization of $227.46 billion, a price-to-earnings ratio of 10.86, a P/E/G ratio of 1.58 and a beta of 0.43. The company has a 50-day moving average of $291.78 and a 200 day moving average of $406.82. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group's revenue for the quarter was up 12.9% on a year-over-year basis. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 3.5%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio is 38.30%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several research reports. JPMorgan Chase & Co. decreased their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a research note on Wednesday. Hsbc Global Res cut shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Baird R W cut shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Wolfe Research reduced their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Finally, Oppenheimer reduced their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $366.52.

Read Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines